Logos Global Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.44M | Sell |
200,000
-150,000
| -43% | -$7.08M | 1.04% | 26 |
|
|
2025
Q1 | $13.7M | Buy |
+350,000
| New | +$13.7M | 2.43% | 16 |
|
|
2024
Q3 | – | Sell |
-750,000
| Closed | -$33M | – | 60 |
|
|
2024
Q2 | $33M | Buy |
+750,000
| New | +$33M | 2.65% | 10 |
|
|
2024
Q1 | – | Sell |
-150,000
| Closed | -$9.06M | – | 59 |
|
|
2023
Q4 | $9.06M | Buy |
+150,000
| New | +$9.06M | 0.85% | 23 |
|
|
2021
Q3 | – | Sell |
-50,000
| Closed | -$518K | – | 63 |
|
|
2021
Q2 | $518K | Sell |
50,000
-150,000
| -75% | -$1.55M | 0.04% | 55 |
|
|
2021
Q1 | $2.04M | Hold |
200,000
| – | – | 0.2% | 51 |
|
|
2020
Q4 | $2.27M | Buy |
+200,000
| New | +$2.27M | 0.19% | 49 |
|